Agilon Health Intrinsic Value Calculator – Truist Financial Decreases agilon health Price Target to $23.00
November 16, 2023
🌥️Trending News
AGILON HEALTH ($NYSE:AGL) is an innovative technology-enabled healthcare services and solutions company that is transforming the way primary care is organized and delivered. With their groundbreaking technology, focused on care coordination and physician collaboration, they are providing more efficient care and improved outcomes for patients nationwide. Recently, Truist Financial has revised its price target for AGILON HEALTH to $23.00. This decision was based on the company’s strong performance and the potential for growth in the future. The reduction of the price target reflects the current market conditions and is not a reflection of AGILON HEALTH’s recent performance. The company has continued to show impressive growth in the past year and is well-positioned to capitalize on the expanding healthcare market.
In addition, Truist Financial also noted that AGILON HEALTH’s strategic partnerships are likely to help them continue to expand their presence in the healthcare market. Overall, Truist Financial’s decision to decrease AGILON HEALTH’s price target comes as no surprise given their strong performance in the past year. Investors should be aware of the potential upside of this stock and should keep an eye on AGILON HEALTH’s progress as it continues to innovate and expand its services.
Share Price
Monday was a difficult day for AGILON HEALTH, as Truist Financial’s analysts decreased their price target for the company to $23.00. This news caused the stock to open at $11.4 and close at $11.2, representing a 1.3% decrease from the prior closing price of 11.3. This drop in price has likely caused concern among investors, as they now evaluate the potential impact this news may have on the company’s future performance.
Despite the decrease in price target, AGILON HEALTH still stands to benefit from its recent developments in digital healthcare solutions, and its potential to become a leader in the industry. As such, investors should continue to monitor the company’s progress and evaluate their own risk tolerance before making any further investment decisions. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Agilon Health. More…
| Total Revenues | Net Income | Net Margin |
| 4.19k | -88.63 | -2.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Agilon Health. More…
| Operations | Investing | Financing |
| -144.99 | -49.79 | -191.16 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Agilon Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.28k | 1.41k | 2.15 |
Key Ratios Snapshot
Some of the financial key ratios for Agilon Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 50.5% | – | -1.9% |
| FCF Margin | ROE | ROA |
| -4.0% | -5.8% | -2.2% |
Analysis – Agilon Health Intrinsic Value Calculator
At GoodWhale, we recently ran an analysis of AGILON HEALTH‘s financials. After thorough research, we have concluded that the fair value of AGILON HEALTH share is around $42.7. This figure is calculated using our proprietary Valuation Line model. This means that AGILON HEALTH stock is currently traded at $11.2, which is undervalued by 73.8%. This presents a great opportunity for potential investors to benefit from the economic mispricing. More…
Peers
Its competitors include P3 Health Partners Inc, Oak Street Health Inc, and Pathway Health Corp.
– P3 Health Partners Inc ($NASDAQ:PIII)
P3 Health Partners Inc is a US-based healthcare company that provides services and products to health plans, provider groups, and individuals. The company has a market capitalization of 212.47 million as of 2022 and a return on equity of 196.33%. P3 Health Partners Inc is a leading provider of healthcare services and products in the United States. The company offers a wide range of services and products, including health insurance, provider services, and individual products. P3 Health Partners Inc is a publicly traded company listed on the New York Stock Exchange.
– Oak Street Health Inc ($NYSE:OSH)
Oak Street Health Inc is a healthcare services company that operates primary care centers for adults on Medicare in the United States. As of December 31, 2020, the company operated 109 primary care centers in Illinois, Indiana, Michigan, New Jersey, Pennsylvania, and Rhode Island. The company was founded in 2013 and is headquartered in Chicago, Illinois.
– Pathway Health Corp ($TSXV:PHC)
Pathway Health Corp has a market cap of 4.69M as of 2022, a Return on Equity of -239.69%. The company provides healthcare services to skilled nursing and assisted living facilities.
Summary
This reflects an 11% decrease in the stock’s expected return. Investors should take this into consideration when evaluating Agilon Health as an investment opportunity. A thorough analysis of the company’s financial performance and the competitive dynamics of the healthcare sector can help investors understand the risks associated with investing in the company. Analysts have pointed out Agilon Health’s strong financial performance in terms of revenue growth, strong cash flows, and healthy balance sheet. The company has also demonstrated strong customer demand, with a large addressable market for its products and services.
Additionally, Agilon Health has focused on improving its cost structure by implementing more efficient processes and systems. Investors should carefully consider these factors and evaluate the company’s risk profile before making a decision about investing.
